Skip to content

Public FDA record

Z-2775-2015: Angiographic Injector. Medrad Mark 7 Arterion Injection System, which utilizes Software Version SW 005.00

Recall record Z-2775-2015 for Bayer Healthcare. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2775-2015
Company in FDA record
Bayer Healthcare
FDA classification date
Sep 16, 2015
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Software Version SW 005.006_SH, resulted in the removal of purge enforcement from traditional New-Case, Power Up and Syringe Change use cases while the injector head is in the upright position.

Source facts

Action
Direct accounts were notified by UPS Notification letter dated August 4, 2015 and advised when using the Arterion Injection System to ensure that purges are completed to avoid the injection of air.
Initiated
2015-08-04
Root cause
Software design
Terminated
2016-08-17
Distribution
Worldwide Distribution. US Nationwide, Germany, France, UK, Netherlands, Sweden, and Canada.
Recall number
Z-2775-2015
Recall status
Terminated
CDRH record ID
139674
FDA classified
2015-09-16
Recall event number
71994

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗